Cannabinoid hyperemesis syndrome found to have increased from 2012 to 2021

From 2012 to 2021, there was an increase in the prevalence of cannabinoid hyperemesis syndrome (CHS) in Massachusetts, with the highest 10-year prevalence among young adults, Hispanic individuals, Black individuals, and men, according to a study published in the American Journal of Gastroenterology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup